Cardiovascular and pulmonary effects of aerosolized prostacyclin administration in severe respiratory failure using a ventilator nebulization system

被引:20
作者
Bein, T
Metz, C
Keyl, C
Sendtner, E
Pfeifer, M
机构
[1] UNIV REGENSBURG, UNIV HOSP, DEPT CARDIOTHORAC SURG, D-93042 REGENSBURG, GERMANY
[2] UNIV REGENSBURG, UNIV HOSP, DEPT INTERNAL MED 2, D-93042 REGENSBURG, GERMANY
关键词
respiratory failure; acute pulmonary hypertension; prostacyclin; aerosolization;
D O I
10.1097/00005344-199604000-00019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the effects of aerosolized prostacyclin (PGI(2)) administration on hemodynamics and pulmonary gas exchange in 8 patients with severe respiratory failure and acute pulmonary hypertension. Nebulization of epoprostenol (5 ng/kg body weight for 15 min) decreased mean pulmonary blood pressure from 41.2 +/- 6.7 mm Hg (mean +/- SD, before administration) to 36.1 +/- 6 mm Hg less than or equal to 15 min (p < 0.05). The effect was reversed 10 min after discontinuation of PGI(2) (40.9 +/- 6.3 mm Hg). Pulmonary vascular resistance index (339 +/- 138 dynes . s . cm(-5) . m(2), before administration) was significantly (p < 0.05) reduced less than or equal to 15 min (260 +/- 89 dynes . s . cm(-5) . m(2)) and increased again after discontinuation of PGI(2) (341 +/- 142 dynes . s . cm(-5) . m(2)). The ratio of arterial oxygen to the fraction of inspired oxygen (PaO2/FiO(2)) increased from 119 +/- 34 mm Hg (before administration) to 163 +/- 76 mm Hg (15 min after initiation of administration p < 0.05) and was reduced after PGI(2) discontinuation (116 +/- 35 mm Hg). Heart rate, mean blood pressure, central venous pressure, and pulmonary arterial wedge pressure remained unchanged, whereas cardiac index was slightly reduced. We assume that PGI(2) aerosolization is a beneficial technique, applied with a ventilator nebulization system. The beneficial effect might be caused by selective pulmonary vasodilatation in well-ventilated areas of the lung.
引用
收藏
页码:583 / 586
页数:4
相关论文
共 12 条
  • [1] CONTINUOUS INTRAARTERIAL MEASUREMENT OF OXYGENATION DURING AEROSOLIZED PROSTACYCLIN ADMINISTRATION IN SEVERE RESPIRATORY-FAILURE
    BEIN, T
    PFEIFER, M
    RIEGGER, GAJ
    TAEGER, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (05) : 335 - 336
  • [2] MONCADA S, 1978, PHARMACOL REV, V30, P293
  • [3] AN EXPANDED DEFINITION OF THE ADULT RESPIRATORY-DISTRESS SYNDROME
    MURRAY, JF
    MATTHAY, MA
    LUCE, JM
    FLICK, MR
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (03): : 720 - 723
  • [4] PROSTACYCLIN AND ACETYLCHOLINE AS SCREENING AGENTS FOR ACUTE PULMONARY VASODILATOR RESPONSIVENESS IN PRIMARY PULMONARY-HYPERTENSION
    PALEVSKY, HI
    LONG, W
    CROW, J
    FISHMAN, AP
    [J]. CIRCULATION, 1990, 82 (06) : 2018 - 2026
  • [5] PROSTACYCLIN AND RIGHT VENTRICULAR-FUNCTION IN PATIENTS WITH PULMONARY-HYPERTENSION ASSOCIATED WITH ARDS
    RADERMACHER, P
    SANTAK, B
    WUST, HJ
    TARNOW, J
    FALKE, KJ
    [J]. INTENSIVE CARE MEDICINE, 1990, 16 (04) : 227 - 232
  • [6] REDL G, 1992, INTENS CARE MED, V19, P3
  • [7] INHALED NITRIC-OXIDE FOR THE ADULT RESPIRATORY-DISTRESS SYNDROME
    ROSSAINT, R
    FALKE, KJ
    LOPEZ, F
    SLAMA, K
    PISON, U
    ZAPOL, WM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (06) : 399 - 405
  • [8] WALMRATH D, 1995, AM J RESP CRIT CARE, V151, P724
  • [9] AEROSOLIZED PROSTACYCLIN IN ADULT-RESPIRATORY-DISTRESS-SYNDROME
    WALMRATH, D
    SCHNEIDER, T
    PILCH, J
    GRIMMINGER, F
    SEEGER, W
    [J]. LANCET, 1993, 342 (8877) : 961 - 962
  • [10] PGI2 AEROSOL VERSUS NITRIC-OXIDE FOR SELECTIVE PULMONARY VASODILATION IN HYPOXIC PULMONARY VASOCONSTRICTION
    WELTE, M
    ZWISSLER, B
    HABAZETTL, H
    MESSMER, K
    [J]. EUROPEAN SURGICAL RESEARCH, 1993, 25 (05) : 329 - 340